{"version":"1.0","provider_name":"Myanmar News Gazette","provider_url":"https:\/\/myanmarnewsgazette.com","author_name":"admin","author_url":"https:\/\/myanmarnewsgazette.com\/author\/admin\/","title":"Junshi Biosciences Announces Approval for Marketing of VV116 in China - Myanmar News Gazette","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"Pee92dykPT\"><a href=\"https:\/\/myanmarnewsgazette.com\/junshi-biosciences-announces-approval-for-marketing-of-vv116-in-china\/\">Junshi Biosciences Announces Approval for Marketing of VV116 in China<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/myanmarnewsgazette.com\/junshi-biosciences-announces-approval-for-marketing-of-vv116-in-china\/embed\/#?secret=Pee92dykPT\" width=\"600\" height=\"338\" title=\"&#8220;Junshi Biosciences Announces Approval for Marketing of VV116 in China&#8221; &#8212; Myanmar News Gazette\" data-secret=\"Pee92dykPT\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n<\/script>\n","description":"SHANGHAI, China, Jan. 30, 2023 (GLOBE NEWSWIRE) \u2014 Shanghai Junshi Biosciences Co., Ltd (\u201cJunshi Biosciences\u201d, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced today that the National Medical Products Administration (the \u201cNMPA\u201d) has conducted urgent review and approval under Special Examination and Approval [\u2026]","thumbnail_url":"https:\/\/ci4.googleusercontent.com\/proxy\/tGwBrnW1USbzzigywwQXDqEWNKNArvfbZPYLoSawIoGZGGPfr2wg2U23OkMWV6CaNvmJ_8WNHkcvLjeHyMB5vajf4sL4UQP2B4t25c1J1gsJeMkj371vCA5NxOArXP20yOwjQLf9iuXt3LtIJXCa_M3oQ3YBzaVgyc7j_6KrbcrcW1TYE5bh2NXwFtd29g=s0-d-e1-ft#https:\/\/ml.globenewswire.com\/media\/MTg1YWZkOWEtNDNhNi00OTA3LWIzZmMtMzQ0OWQ3ZTllZDFiLTEyMDY5Mjg=\/tiny\/Junshi-Biosciences.png"}